{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:48:39Z","timestamp":1790567319787,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":4056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.exphem.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T05:43:51Z","timestamp":1297489431000},"page":"546-557.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment"],"prefix":"10.1016","volume":"39","author":[{"given":"Caroline","family":"Bret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Reme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alboukadel","family":"Kassambara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Mei\u00dfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Schved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Kanouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.02.002_bib1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.exphem.2011.02.002_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20040424","article-title":"The ADAMTS metalloproteinases","volume":"15","author":"Porter","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2011.02.002_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10555-006-7889-6","article-title":"ADAMs, cell migration and cancer","volume":"25","author":"Arribas","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.exphem.2011.02.002_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrc2459","article-title":"The ADAMs: signalling scissors in the tumour microenvironment","volume":"8","author":"Murphy","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2011.02.002_bib5","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-0398-3","article-title":"Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma","volume":"10","author":"Porter","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2011.02.002_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.bjc.6603006","article-title":"Expression of ADAMTS-8, a secreted protease with antiangiogenic properties, is downregulated in brain tumours","volume":"94","author":"Dunn","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2011.02.002_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pros.20182","article-title":"The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbetal in prostate cells: relevance to the accumulation of versican","volume":"63","author":"Cross","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.exphem.2011.02.002_bib8","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1158\/0008-5472.CAN-08-0548","article-title":"ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo","volume":"68","author":"Rocks","year":"2008","journal-title":"Cancer Res"},{"issue":"Pt 20","key":"10.1016\/j.exphem.2011.02.002_bib9","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1242\/jcs.005751","article-title":"The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway","volume":"120","author":"Llamazares","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2011.02.002_bib10","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"Sprynski","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood-2008-10-184226","article-title":"Induction of angiogenesis by normal and malignant plasma cells","volume":"114","author":"Hose","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/bj3180459","article-title":"Cloning of a novel membrane-linked metalloproteinase from human myeloma cells","volume":"318","author":"McKie","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2011.02.002_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/bbrc.1997.6714","article-title":"Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies","volume":"235","author":"Wu","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2011.02.002_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"Atanackovic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib15","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood-2005-09-3830","article-title":"ADAM-9 (MDC-9\/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin","volume":"107","author":"Karadag","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3324\/haematol.13426","article-title":"MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells","volume":"94","author":"Brito","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2011.02.002_bib17","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood-2004-04-1385","article-title":"Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic\/plasmablastic tumors","volume":"105","author":"Guedez","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.leukres.2008.04.001","article-title":"Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients","volume":"32","author":"Zdzisinska","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2011.02.002_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1365-2141.1998.00754.x","article-title":"Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor","volume":"101","author":"Hargreaves","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2011.02.002_bib20","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma","volume":"83","author":"Zhang","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib21","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V91.12.4727","article-title":"A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma","volume":"91","author":"Rebouissou","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.163.1.514","article-title":"Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells","volume":"163","author":"Tarte","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2011.02.002_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.leu.2401632","article-title":"Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors","volume":"14","author":"Gu","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2011.02.002_bib24","article-title":"A high-risk signature for patients with multiple myeloma established from human myeloma cell lines molecular classification","author":"Moreaux","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2011.02.002_bib25","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","article-title":"Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells","volume":"24","author":"Mahtouk","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib26","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2009-07-235960","article-title":"An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization","volume":"114","author":"Jourdan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.V100.4.1113.h81602001113_1113_1122","article-title":"Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts","volume":"100","author":"Tarte","year":"2002","journal-title":"Blood"},{"issue":"suppl 2","key":"10.1016\/j.exphem.2011.02.002_bib28","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.bmt.1702348","article-title":"Autologous and allogeneic stem cell transplantation in multiple myeloma","volume":"25","author":"Goldschmidt","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2011.02.002_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2011.02.002_bib30","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood-2005-10-4084","article-title":"Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies","volume":"107","author":"Barlogie","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2011.02.002_bib32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","article-title":"The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature","volume":"106","author":"Moreaux","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib33","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2010-04-279760","article-title":"Osteoclast-gene expression profiling reveals osteoclast-derived CCR2-chemokines promoting myeloma cell migration","volume":"117","author":"Moreaux","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.02.002_bib34","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1038\/sj.onc.1205868","article-title":"Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays","volume":"21","author":"De Vos","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2105-9-16","article-title":"A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments","volume":"9","author":"Reme","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.exphem.2011.02.002_bib36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1634\/stemcells.2006-0352","article-title":"A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas","volume":"25","author":"Assou","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2011.02.002_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09674845.2009.11730257","article-title":"ADAMs and ADAMTSs in cancer","volume":"66","author":"Turner","year":"2009","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.exphem.2011.02.002_bib38","doi-asserted-by":"crossref","first-page":"29251","DOI":"10.1074\/jbc.274.41.29251","article-title":"MDC-L, a novel metalloprotease disintegrin cysteine-rich protein family member expressed by human lymphocytes","volume":"274","author":"Roberts","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.02.002_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/sj.emboj.7600548","article-title":"ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling","volume":"24","author":"Reiss","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2011.02.002_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/jid.2008.323","article-title":"ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells","volume":"129","author":"Anderegg","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.exphem.2011.02.002_bib41","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/hmg\/11.21.2615","article-title":"The disintegrin\/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts","volume":"11","author":"Hartmann","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2011.02.002_bib42","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1073\/pnas.1230693100","article-title":"The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase","volume":"100","author":"Six","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.02.002_bib43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200307137","article-title":"Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands","volume":"164","author":"Sahin","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2011.02.002_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/MCB.24.1.96-104.2004","article-title":"Essential role for ADAM19\u00a0in cardiovascular morphogenesis","volume":"24","author":"Zhou","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2011.02.002_bib45","doi-asserted-by":"crossref","first-page":"e3322","DOI":"10.1371\/journal.pone.0003322","article-title":"Meltrin beta\/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction","volume":"3","author":"Yumoto","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2011.02.002_bib46","doi-asserted-by":"crossref","first-page":"42898","DOI":"10.1074\/jbc.M403193200","article-title":"Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE\/ADAM17)","volume":"279","author":"Zheng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.02.002_bib47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-4838(99)00279-4","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and function","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2011.02.002_bib48","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1242\/jcs.00063","article-title":"Metalloproteinase inhibitors: biological actions and therapeutic opportunities","volume":"115","author":"Baker","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2011.02.002_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1523-1747.ep12483956","article-title":"Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases","volume":"97","author":"Bertaux","year":"1991","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.exphem.2011.02.002_bib50","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(92)80386-U","article-title":"Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity","volume":"296","author":"Stetler-Stevenson","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2011.02.002_bib51","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1242\/jcs.107.9.2373","article-title":"Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)","volume":"107","author":"Hayakawa","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2011.02.002_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/excr.1996.0117","article-title":"TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin","volume":"224","author":"Nemeth","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2011.02.002_bib53","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.yexcr.2005.11.022","article-title":"Making the cut: protease-mediated regulation of angiogenesis","volume":"312","author":"Roy","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2011.02.002_bib54","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/sj.onc.1207263","article-title":"Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors","volume":"23","author":"Costa","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib55","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1038\/sj.onc.1207783","article-title":"Identification of 27 5\u2019 CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers","volume":"23","author":"Hagihara","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib56","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/sj.onc.1208952","article-title":"ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation","volume":"24","author":"Takada","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib57","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ijc.24023","article-title":"Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues","volume":"124","author":"Choi","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2011.02.002_bib58","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1091\/mbc.11.4.1457","article-title":"ADAM 23\/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism","volume":"11","author":"Cal","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.exphem.2011.02.002_bib59","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.onc.1209767","article-title":"Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9","volume":"26","author":"Lo","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.02.002_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ijc.23528","article-title":"Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma","volume":"123","author":"Lung","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2011.02.002_bib61","doi-asserted-by":"crossref","first-page":"29077","DOI":"10.1074\/jbc.M109.014258","article-title":"Structural characterization of the ectodomain of a disintegrin and metalloproteinase-22 (ADAM22), a neural adhesion receptor instead of metalloproteinase: Insights on ADAM function","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.02.002_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0006-291X(03)00056-1","article-title":"The interaction between ADAM 22 and 14-3-3zeta: regulation of cell adhesion and spreading","volume":"301","author":"Zhu","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2011.02.002_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1227\/01.NEU.0000192363.84287.8B","article-title":"ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain","volume":"58","author":"D\u2019Abaco","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.exphem.2011.02.002_bib64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2003.12.029","article-title":"ADAM gene expression and regulation during human osteoclast formation","volume":"35","author":"Verrier","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.exphem.2011.02.002_bib65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2004.01.022","article-title":"ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3","volume":"315","author":"Mochizuki","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2011.02.002_bib66","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1158\/0008-5472.CAN-06-0377","article-title":"ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3","volume":"66","author":"Mitsui","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2011.02.002_bib67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00251-002-0430-3","article-title":"The ADAMDEC1 (decysin) gene structure: evolution by duplication in a metalloprotease gene cluster on chromosome 8p12","volume":"54","author":"Bates","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.exphem.2011.02.002_bib68","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10555-007-9093-8","article-title":"RECK\u2013a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer","volume":"26","author":"Clark","year":"2007","journal-title":"Cancer Metastasis Rev"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:28:31Z","timestamp":1759566511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0301472X11000634"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.02.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}